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INTRODUCTION
Cervical cancer still becomes the main health prob-
lem in the world. World Health Organization
(WHO) in 2012 stated that this disease ranked the
fourth most prevalent cancer among women.
Approximately 528,000 new cases are detected
each year, 85% of which are found in developing
countries. From those cases, 266,000 cases die,
where 9 of 10 death cases occur in developing
countries.1 In 2011, Cancer Registry Council of
Pathology Specialist Association in Indonesia
stated that this disease was the second most pre-
valent cancer in women with the incidence rate of
3,047 (12.27%).2
Cervical cancer has higher rate of incidence in
developing countries compared with developed
ones. Furthermore, patients suffering from cervical
cancer in developing countries are often diagnosed
at advanced stage of diseases so that the 5-year
survival rate is less than 40%.3 Actually, the
disease requires 10-20 years to transform from
pre-cancer lesions to cancer and whenever it
reaches the advanced stage, the survival rate drops
significantly. Compared with its first stage, the
second, third, and fourth stage have an estimated
hazard ratio of 3.09, 18.11, and 53.03; respec-
tively.4,5
Structured screening program for cervical
cancer is responsible for decreasing the incidence
and mortality rate of cervical cancer in developed
countries. In United States, the incidence of cervical
cancer had dropped by 70% for the last 50
years.6 Unfortunately, in the developing countries,
the screening is not distributed equally and the
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Abstrak
Tujuan: Untuk mengevaluasi efektivitas dan keamanan krioterapi
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coverage is still low. Only 5% of the population has
access to the screening program. Apart from that,
the health care service is not comprehensive and
holistic causing the high prevalence of cervical
cancer. This problem also includes of low aware-
ness of the disease among the population. As the
population grows, there will be an increase num-
ber of cervical cancer patients.7,8
World Health Organization analyzed that in the
developing countries, screening program using Pap
smear cannot significantly decrease the incidence
and mortality rate of cervical cancer. Limited
budget, low competent resources, and inadequate
health care system contribute to the failure of Pap
smear screening in those countries.9 Visual inspec-
tion with acetic acid (VIA) is known as the alterna-
tive effective method in detecting precancerous le-
sion in the developing countries. It is both sensitive
(67-92.3%) and specific (49-99.8%).10,11 Therefore,
VIA is considered as one of the most popular
screening method for precancer lesion, especially in
low-resource health care facility.12
The management of precancerous lesion involves
cryotherapy, loop electrosurgical excision proce-
dure (LEEP), laser, and knife conization.5 However,
the limitation of the resource makes screening
methods is not feasibly perform. Therefore, to han-
dle this problem, Indonesia has "See and Treat" pro-
gram, namely screening using VIA and manage-
ment through cryotherapy.13 The effectivity of
cryotherapy in treating the precan-cerous lesion
ranges from 81.4% to 96.4% for cervical intraepi-
thelial lesion (CIN) I and from 68% to 82.1% for
CIN II-III.14-17 The complaint after cryo-therapy pro-
cedure is around 5.6%, including minimal bleeding
(1.3%). There is no major complication reported af-
ter cryotherapy.15,18
In Indonesia, the evaluation of IVA after
cryotherapy in "See and Treat" program had been
done between 2004 and 2006; the effectivity
reached 92%.16 However, data about the effective-
ness of cryotherapy in Indonesia after 2006 was
still limited. Therefore, this study aims to describe
the VIA result after cryotherapy in "See and Treat"
program in Indonesia.
METHODS
We used descriptive cross-sectional study design
using medical records from 2010 to 2015. We
recruited by total sampling method. "See and treat"
program was a single-visit approach program
implemented at the low-resource primary health
care in Indonesia. It aimed to diagnose the cervix
precancerous lesion through VIA and treat positive
VIA result with cryotherapy in Indonesia. The
evaluation of VIA conversion was performed 6
months after cryotherapy. Every patient’s data was
written on the medical record.
Participants
We included all women who had positive result of
VIA, had received the cryotherapy as treatment;
then they visited to control in 6 months after
cryotherapy and we could track the complete
medical records in primary health care. We catego-
rized lost-to-follow-up for subjects who could not
be recalled due to inactive number or unavailable
contact. Therefore, we excluded those criteria.
Procedure
History taking and physical examination were per-
formed by the general practitioner in primary
health care to exclude the cervicitis, nabothian cyst,
and polyp. We detected the cervical precancerous
lesion by using a 5% diluted acetic acid solution.
The result of VIA was inspected visually with ade-
quate light source. It was considered positive result
if there were acetowhite lesions on the transitional
zone close to the squamocolumnar junction. When
the VIA result was positive, cryotherapy become
the choice of treatment in this program. Cryo-
therapy using cryoprobe was provided in two
cycles, with 3 minutes of freeze and 5 minutes of
thaw in each cycle. After the process, we prescribed
the analgesic and a dose of antibiotic. We also in-
formed the side effects of cryotherapy and in-
struction not to have sexual intercourse for a
month. The patient was informed to come for
follow-up session in a month and six months after-
wards. The one-month follow-up after cryotherapy
aimed to assess the side effect of cryotherapy, such
as severe abdominal cramp, fever more than 38°C,
or bloody and purulent discharge. The six-month
follow-up after cryotherapy would like to assess the
conversion of VIA. Patients had the conversion of
VIA if the VIA result became negative on six-month
follow-up. Failure of cryotherapy was divided into
failure to achieve VIA conversion and suspected
invasive cancer. Further follow-up was done to
observe the cause of cryotherapy failure. We took
the data from the medical record; thus, we had to
contact the subject in every missing data.
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Calculation and data management
Data were analyzed univariately by separating the
conversion of VIA on the six-month follow-up into
three groups, namely successful conversion, failure
to convert, and suspected invasive cancer. We
analyzed the data through Microsoft Excel.
RESULTS
From 2010 to 2015, there were 143 medical re-
cords which showed the positive VIA result. Fifty-
seven (39.86%) data were excluded because 8 of
them (5.59%) did not do the cryotherapy and the
rest of them (49 data) were lost to follow-up. Four
data (2.80%) were dropped out due to missing
data. Therefore, there were only 86 (57.34%) data
continuing to analyze.
Demographic Characteristics
Of 86 medical records, most of the subjects were
30-39 years old (40.7%) with the first-marriage
age of 20-24 years old (52.3%), having 1 to 3
children, and never smoke (98.84%). The number
of subjects using hormonal and non-hormonal
contraceptive were similar (33.72% vs 29.07%).
Table 1. Characteristics of Subjects
Variables n % Median (min­max)
Age (years old) 35.0 (19.0-57.0)
<20 1 1.2
20-29 18 20.9
30-39 35 40.7
40-49 28 32.6
50-59 4 4.7
First-marriage age (years old) 23.0 (16.0-33.0)
<20 16 18.6
20-24 45 52.3
25-29 19 22.1
30-34 6 7.0
History of contraceptive usage
None 20 23.26
Pill 15 17.44
Intrauterine device (IUD) 25 29.07
Injection 14 16.28
Implant 2 2.32
Sterile 0 0
Condom 0 0
Combination 10 11.63
Number of marriage (times)
1 85 98.84
2 1 1.16
Parity
0 5 5.81
1 27 31.40
2 26 30.23
3 21 24.42
4 6 6.98
5 1 1.16
Smoking
No 85 98.84
Yes 1 1.16
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The VIA Result Six Months after
Cryotherapy
"See and Treat" program required the patients to
do the repeated VIA test on the six months after
cryotherapy to assess the conversion of VIA result.
There were 90.70% cases of VIA positive cases
converting to negative; while, the rest of the cases
did not show the conversion. None of the cases
were progress to become the invasive cancer
(Table 2).
Table 2. VIA Result Six Months after Cryotherapy
n %
IVA - 78 90.70
IVA + 8 9.30
Suspicious of invasive cancer 0 0
Total 86 100
DISCUSSION
"See and Treat" program aims to detect and treat
the cervical cancer from its precancerous lesion at
the low resource setting of primary health care
center.13 This is a single visit approach program
that using VIA to screen and cryotherapy to treat
whether the result is positive. This program can
decrease the lifetime risk of cervical cancer from
35-year-old women who have not been screened
on her entire life.16
The implementation of "See and Treat" program
involves four pillar: Firstly, the training of VIA and
cryotherapy; secondly, improving the awareness of
the society;  thirdly, detection and treatment using
VIA and cryotherapy; the last one is referral system
activation when obtaining a difficult case that has
a high progressivity to cervical cancer.13,16 The
focus of this study is on the third point which aims
to evaluate the VIA conversion after six-month of
cryotherapy.
After six-month of cryotherapy, the conversion
rate of VIA reached 90.7%. Similar study by Vet
JNI, et al. in Jakarta, Tasikmalaya, and Bali from
2007 to 2010 also showed the similar result,
namely 92.0%.19 While it seemed that there was a
drop on the successful conversion rate of 1.3%, the
difference in this proportion did not differ statisti-
cally. It was due to the high prevalence of loss to
follow-up and/or incomplete data (37.07% in this
study VS 52.60% in the Vet JNI, et al study).19 The
target of "See and Treat" conversion rate was still
not available. Looking to the number of successful
cryotherapy which reached 90.7%; thus, the cryo-
therapy could be reliable to convert the VIA result.
Subjects that failed having VIA conversion to
negative were 30-49-year old (75.0%) group with
the first-marriage age of 20-24 years old (87.5%),
history of one marriage (100%), having 2 children
(50%), and non-smoker. According to the theory,
those results were similar to the risk factors of cer-
vical cancer. Aziz MF in 2009 through their study
stated that younger first-marriage age (less than
20 years old) had 8 times risk to be cervical can-
cer.20 Pramita S in 2010 concluded that number of
parity was also related to the cervical cancer
(OR=2.59; 95% CI 1.02-6.61).21 In addition,
smoking could also increase the risk of squamous
cell carcinoma (RR 1.50; 95% CI 1.35-1.66).22,23
Number of marriage in this study was not suitable
to the theory stated that the behaviour of changing
partners increased the incidence of cervical cancer
up to 4 times.20 However, the number of marriages
cannot represent the behaviour of changing
partner.
Based on the history of contraception, 75% of
the subjects who used injection contraceptive
failed to achieve the VIA conversion; while, the
other 25% were using pills as the method of con-
traceptive. That result was similar to the theory
that more than five year consumption of oral con-
traceptive contributed to 1.9 times risk for cervical
cancer.21 We did not count the risk of that although
contraception is one of the risk factors for the VIA
conversion. Although the cryotherapy success rate
in "See and Treat" program reached 90.7%, there
were 8 people (9.3%) who did not show the VIA
conversion to negative. Those patients were then
referred to Dr. Cipto Mangunkusumo Hospital
(RSCM) as the national referral hospital in Indo-
nesia for the further definitive diagnosis and ma-
nagement. The failure of VIA conversion can be
caused by several factors, such as equipment,
healthcare provider, VIA false-positive, and referral
system factor.
Looking to equipment factor, problems that
could be happened came from the cessation and
leaking of gas flow.24 Brief survey from the
healthcare providers in this study showed that the
cryoprobe could sometimes stop automatically
before ending the two cycles of cryotherapy.
Unfortunately, no further information was re-
viewed and analyzed in this study.
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Judging from the healthcare provider factor,
problems, such as technical method error, un-
trained healthcare provider doing the cryotherapy,
and lack of update the new methods became the
burden for the program’s success rate because of
failure for the ablation of the cervical precancerous
lesion. Observation of the cryotherapy process was
performed to evaluate the technique practiced by
the primary healthcare provider. Examining from
the method, the healthcare providers had used the
same method of cryotherapy as what the guideline
recommended including 2-cycle cryotherapy with
3 minutes of freezing and 5 minutes of thawing per
cycle. The healthcare providers were considered
expert in their job as they had done this job for at
least 5 years.
In terms of VIA examination, false positive was
a common interpretation. The right history taking
and interpretation of VIA were necessary to
prevent over diagnosis and overtreatment of the
cervical precancerous lesion. Observing the
process of VIA examination, the supervisor did not
confirm the diagnosis. Therefore, the failure of VIA
conversion could also be caused by missed
diagnosis. In the primary healthcare facilities, the
referral of patients to RSCM was a good decision
to exclude the possibility of false positive diagnosis.
Another problem was related to the implemen-
tation of national healthcare coverage Jaminan Ke-
sehatan Nasional (JKN). In JKN era, the referral sys-
tem follows the level of health care. Therefore, pa-
tients from the primary health care cannot be
referred directly to RSCM. This problem was
occurred on one patient, whereas, she could not be
examined the colposcopy examination due to
unavailable tools in the secondary health care.
However, the difference of protocol in that
hospital contributed to the unsuccessful colpos-
copy referral.
Ideally, every failure of VIA conversion after
cryotherapy should be referred to RSCM to be
evaluated in the "See and Treat" program by
Female Cancer Program. However, tiered referral
system hampered this process. Therefore,
recommended advice was either inviting regional
doctors to participate in this program or modifying
the rules of the referral system to suit this
program.
Other problems could also be seen from the side
of the primary healthcare. We got 6 loss to follow-
up subjects; thus, it made a confusion for the false
positive result. Meanwhile, tracking through phone
number or home address was difficult due to the
lack of identity data recorded in primary health
care.
Taking into consideration of those aspects, the
failure of VIA conversion in "See and Treat" pro-
gram could be caused by lack of cryoprobe quality
to ablate the precancerous lesion; lack of referral
knowledge to ensure the definitive diagnosis as
soon as the conversion failure was known; the
complicated referral system held in Indonesia
contributing to the delayed colposcopy for defini-
tive diagnosis; no policy for primary health care
workers to follow-up post referral patients; lack of
knowledge equalization about referral system for
colposcopy among regional public hospitals.
While failure of VIA conversion was detected, we
did not find the progressing lesion to cervical
cancer. Therefore, VIA and cryotherapy technique
in "See and Treat" program was considered effec-
tive in screening and early treatment for the cer-
vical precancerous lesion cases.
We also evaluated the timing of control after
cryotherapy. While this study and Vet JNI, et al con-
sidered the first and sixth month after cryotherapy
as the suitable control time, WHO recommended
that the control should be done a year after
cryotherapy. The consideration of the first-month
control was to evaluate the side effects of cryo-
therapy; while, the consideration of the sixth-
month control was to evaluate the VIA conversion.
The cut-off of 6 months was considered as the
novelty of this program in Indonesia. Prompt
evaluation of the cases was expected to be able to
minimize the incidence of cervical cancer pro-
gressivity. Two studies having been conducted in
Indonesia proved the constancy of VIA conversion
in this program.
The number of loss to follow-up in Indonesia
was still high. Therefore, the system of patients’
identity registry, such as patients’ telephone
number and the system of reminding patients, such
as by contacting the patients at the time of control
should be considered.
In terms of side effects, the side effect due to
cryotherapy was only happened on one subject. We
could state that cryotherapy was safe enough. This
result was supported by Blumenthal, et al., Vet JNI,
et al., and Fong J, et al. as their studies showed the
similar result.16,18,25 However, they did not
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mention the proportion of side effect occurrence in
post cryotherapy patients. Sankaranarayanan R, et
al. observed that the side effects and complications
of cryotherapy were happened only in a small
proportion of the population and they were not
life-threatening.14 Therefore, cryotherapy was a
safe treatment method for precancerous lesion.
However, there were still no studies that focused
on side effects of cryotherapy. Therefore, further
studies should be held to evaluate the degree of
safety from cryotherapy.
CONCLUSION
More than 90% (90.7%) women showing VIA-
positive have VIA conversion after 6 months of
cryotherapy. We do not find the progression to
invasive cancer in 6 months. Therefore, cryo-
therapy in this program is effective in the early
management cervical precancerous lesion.
RECOMMENDATION
Some recommendations for the next study consist
of the need to evaluate "See and Treat" program
from other aspects to further increasing the
coverage rate; the need of further assessment
about the aetiology of VIA-conversion failure, such
as the false-positive of VIA result, the quality of
cryoprobe, the competency of user, and the impact
of referral system nowadays in contributing to the
barrier of making definitive diagnosis; the regional
doctors should be included in implementing this
program in regional general hospital or the rules
of tiered referral system of JKN should be modified
to suit this program; the recommendation of
a-year control after cryotherapy as mentioned by
WHO can be implemented in Indonesia; the need
of patients’ information registry to remind patients
to control the VIA conversion.
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